Yayın:
Quantitative determination of rivaroxaban in pharmaceutical formulations by ultra performance liquid chromatography

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCAN, NAFİZ ÖNCÜ
dc.contributor.authorNafiz Öncü Can
dc.contributor.orcid0000-0003-3372-4630
dc.contributor.orcid0000-0003-0280-518X
dc.date.accessioned2025-11-18T22:58:17Z
dc.date.issued2024-12-31
dc.identifier.doihttps://doi.org/10.55971/ejls.1535613
dc.identifier.endpage100
dc.identifier.issn2822-5333
dc.identifier.issue3
dc.identifier.openalexW4405946732
dc.identifier.startpage93
dc.identifier.urihttps://hdl.handle.net/11421/17048
dc.identifier.urihttps://doi.org/10.55971/ejls.1535613
dc.identifier.volume3
dc.language.isoen
dc.relation.ispartofEuropean Journal of Life Sciences
dc.rightsopenAccess
dc.subjectRivaroxaban
dc.subjectChromatography
dc.subjectLinearity
dc.subjectHigh-performance liquid chromatography
dc.subjectDosage form
dc.subjectVolumetric flow rate
dc.subjectChemistry
dc.subjectAcetonitrile
dc.subjectPharmaceutical formulation
dc.subjectMaterials science
dc.subjectAnalytical Chemistry (journal)
dc.subjectMedicine
dc.subject.sdg6
dc.titleQuantitative determination of rivaroxaban in pharmaceutical formulations by ultra performance liquid chromatography
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5001553522

Dosyalar

Koleksiyonlar

Publications